{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T14:21:59Z","timestamp":1783606919111,"version":"3.55.0"},"reference-count":28,"publisher":"Bioscientifica","issue":"12","funder":[{"name":"Italian Ministry of Health-Ricerca Corrente"},{"name":"Italian Ministry of Health-Ricerca Finalizzata","award":["GR-2019-12368567"],"award-info":[{"award-number":["GR-2019-12368567"]}]}],"content-domain":{"domain":["journals.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:p>The thyroid differentiation score (TDS), calculated on the expression levels of 16 thyroid function genes, was reported to be lower in BRAF-like than in RAS-like papillary thyroid cancers, but scanty data are available in either other malignant histotypes or in benign thyroid nodules. The aims of the present study were to investigate the clinical relevance of the TDS in a large series of thyroid neoplasms, and its possible role in the differential diagnosis of cytologically indeterminate nodules. The TDS was calculated in 126 differentiated, 20 undifferentiated, 9 non-invasive follicular thyroid neoplasms with papillary-like nuclear features, and 44 benign neoplasms. Overall, TDS significantly and progressively decreased from benign to differentiated and undifferentiated tumors (P &amp;lt; 0.0001). A lower TDS was found in differentiated tumors with higher stage (P = 0.006) and American Thyroid Association (ATA) risk (P = 0.03), radio-iodine resistance (P = 0.008), and disease persistence (P = 0.009). Moreover, TDS independently correlated with progression-free survival, after adjusting for age at diagnosis and ATA risk (P = 0.02). In Bethesda III and IV nodules, the TDS was significantly lower in nodules found to be malignant at histology compared to benign neoplasms (P = 0.004). The combination of TDS with genetic test showed a sensitivity of 78.4%, a specificity of 77.3%, a PPV of 80%, and a NPV of 75.6% (P = 0.001). In conclusion, we found a lower TDS in malignant compared to benign thyroid neoplasms, and demonstrated the prognostic role of TDS in differentiated tumors. These findings could preoperatively improve both the differential diagnosis of cytologically indeterminate nodules and the selection of the best surgical approach.<\/jats:p>","DOI":"10.1530\/erc-25-0167","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T12:09:18Z","timestamp":1763554158000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-8","source":"Crossref","is-referenced-by-count":1,"title":["Clinical relevance of the thyroid differentiation score (TDS) in benign and malignant thyroid tumors"],"prefix":"10.1530","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6288-9509","authenticated-orcid":true,"given":"Marina","family":"Muzza","sequence":"first","affiliation":[{"name":"1"},{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0716-481X","authenticated-orcid":true,"given":"Carla","family":"Colombo","sequence":"additional","affiliation":[{"name":"1"},{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Pogliaghi","sequence":"additional","affiliation":[{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Carbone","sequence":"additional","affiliation":[{"name":"4"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ermellino","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Succi","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Moneta","sequence":"additional","affiliation":[{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianlorenzo","family":"Dionigi","sequence":"additional","affiliation":[{"name":"6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Gentilini","sequence":"additional","affiliation":[{"name":"4"},{"name":"7"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guia","family":"Vannucchi","sequence":"additional","affiliation":[{"name":"1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Gazzano","sequence":"additional","affiliation":[{"name":"2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Persani","sequence":"additional","affiliation":[{"name":"1"},{"name":"5"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fugazzola","sequence":"additional","affiliation":[{"name":"1"},{"name":"3"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","published-online":{"date-parts":[[2025,11,17]]},"reference":[{"key":"2026070909465207900_bib1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa1203208","article-title":"Preoperative diagnosis of benign thyroid nodules with indeterminate cytology","volume":"367","author":"Alexander","year":"2012","journal-title":"N Engl J Med"},{"key":"2026070909465207900_bib2","volume-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017","edition":"edn 8."},{"key":"2026070909465207900_bib3","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr Pathol"},{"key":"2026070909465207900_bib5","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1210\/clinem\/dgab851","article-title":"Characterization of subtypes of BRAF-mutant papillary thyroid cancer defined by their thyroid differentiation score","volume":"107","author":"Boucai","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909465207900_bib6","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1158\/1078-0432.CCR-22-2882","article-title":"Genomic and transcriptomic characteristics of metastatic thyroid cancers with exceptional responses to radioactive iodine therapy","volume":"29","author":"Boucai","year":"2023","journal-title":"Clin Cancer Res"},{"key":"2026070909465207900_bib7","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Cell"},{"key":"2026070909465207900_bib8","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1089\/thy.2017.0500","article-title":"The 2017 bethesda system for reporting thyroid cytopathology","volume":"27","author":"Cibas","year":"2017","journal-title":"Thyroid"},{"key":"2026070909465207900_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1089\/thy.2018.0339","article-title":"Impact of mutation density and heterogeneity on papillary thyroid cancer clinical features and remission probability","volume":"29","author":"Colombo","year":"2019","journal-title":"Thyroid"},{"key":"2026070909465207900_bib10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1530\/ERC-20-0511","article-title":"The thyroid risk score (TRS) for nodules with indeterminate cytology","volume":"28","author":"Colombo","year":"2021","journal-title":"Endocr Relat Cancer"},{"key":"2026070909465207900_bib11","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-25-0022","article-title":"Alterations in gene expression associated with invasion of RAS-mutant thyroid tumors and their potential diagnostic and therapeutic utility","volume":"14","author":"Condello","year":"2025","journal-title":"Eur Thyroid J"},{"key":"2026070909465207900_bib12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jasc.2025.04.003","article-title":"Performance characteristics of ThyroSeq, ThyGeNEXT\/ThyraMIR, and Afirma molecular platforms in evaluation of 1252 cytologically-indeterminate thyroid nodules","volume":"14","author":"Connelly","year":"2025","journal-title":"J Am Soc Cytopathology"},{"key":"2026070909465207900_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association Guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"2026070909465207900_bib14","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1089\/thy.2013.0317","article-title":"Malignancy rate in thyroid nodules classified as bethesda category III (AUS\/FLUS)","volume":"24","author":"Ho","year":"2014","journal-title":"Thyroid"},{"key":"2026070909465207900_bib15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12020-015-0785-5","article-title":"A meta-analysis-derived proposal for a clinical, ultrasonographic, and cytological scoring system to evaluate thyroid nodules: the \u201cCUT\u201d score","volume":"52","author":"Ianni","year":"2016","journal-title":"Endocrine"},{"key":"2026070909465207900_bib16","doi-asserted-by":"crossref","first-page":"e698","DOI":"10.1210\/clinem\/dgad181","article-title":"Bethesda III and IV thyroid nodules managed nonoperatively after molecular testing with Afirma GSC or thyroseq v3","volume":"108","author":"Kim","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909465207900_bib17","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/his.12461","article-title":"Next-generation sequencing improves the diagnosis of thyroid FNA specimens with indeterminate cytology","volume":"66","author":"Le Mercier","year":"2015","journal-title":"Histopathology"},{"key":"2026070909465207900_bib18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12902-025-01867-7","article-title":"Nomogram for predicting the risk of cervical lymph node metastases and recurrence in papillary thyroid carcinoma based on the thyroid differentiation score system and clinical characteristics","volume":"25","author":"Liu","year":"2025","journal-title":"BMC Endocr Disord"},{"key":"2026070909465207900_bib19","doi-asserted-by":"crossref","first-page":"5857","DOI":"10.3390\/cancers14235857","article-title":"Oxidative stress correlates with more aggressive features in thyroid cancer","volume":"14","author":"Muzza","year":"2022","journal-title":"Cancers"},{"key":"2026070909465207900_bib20","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1530\/ERC-17-0532","article-title":"Immune landscape of papillary thyroid cancer and immunotherapeutic implications","volume":"25","author":"Na","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"2026070909465207900_bib22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/cncy.22112","article-title":"Clinical validation of the thyroSeq v3 genomic classifier in thyroid nodules with indeterminate FNA cytology","volume":"127","author":"Nikiforov","year":"2019","journal-title":"Cancer Cytopathology"},{"key":"2026070909465207900_bib23","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1002\/cncr.29038","article-title":"Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm\/suspicious for a follicular neoplasm cytology by thyroSeq v2 next-generation sequencing assay","volume":"120","author":"Nikiforov","year":"2014","journal-title":"Cancer"},{"key":"2026070909465207900_bib24","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1089\/thy.2024.0310","article-title":"Association between gross features and coexistence of BRAF(V600E) and TERT promoter mutations in papillary thyroid carcinomas: a combined analysis incorporating clinicopathologic features","volume":"34","author":"Nguyen","year":"2024","journal-title":"Thyroid"},{"key":"2026070909465207900_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000478927","article-title":"European Thyroid Association Guidelines for ultrasound malignancy risk stratification of thyroid nodules in adults: the EU-TIRADS","volume":"6","author":"Russ","year":"2017","journal-title":"Eur Thyroid J"},{"key":"2026070909465207900_bib26","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/dc.25311","article-title":"ThyroSeq overview on indeterminate thyroid nodules: an institutional experience","volume":"52","author":"Sirotnikov","year":"2024","journal-title":"Diagn Cytopathol"},{"key":"2026070909465207900_bib27","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.surg.2023.07.042","article-title":"Clinical utility of a microRNA classifier in cytologically indeterminate thyroid nodules with RAS mutations: a multi-institutional study","volume":"175","author":"Tumati","year":"2024","journal-title":"Surgery"},{"key":"2026070909465207900_bib28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12935-021-01939-3","article-title":"Identification of an immune-related signature indicating the dedifferentiation of thyroid cells","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Cell Int"},{"key":"2026070909465207900_bib29","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1210\/clinem\/dgae532","article-title":"The association between thyroid differentiation score and survival outcomes in papillary thyroid carcinoma","volume":"110","author":"Wang","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"2026070909465207900_bib30","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1007\/s00330-020-06722-y","article-title":"Pattern-based vs. score-based guidelines using ultrasound features have different strengths in risk stratification of thyroid nodules","volume":"30","author":"Yoon","year":"2020","journal-title":"Eur Radiol"}],"container-title":["Endocrine-Related Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/erc.bioscientifica.com\/view\/journals\/erc\/32\/12\/ERC-25-0167.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/erc.bioscientifica.com\/downloadpdf\/journals\/erc\/32\/12\/ERC-25-0167.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0167\/505934\/erc-25-0167.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article-pdf\/doi\/10.1530\/ERC-25-0167\/505934\/erc-25-0167.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T13:47:03Z","timestamp":1783604823000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.bioscientifica.com\/erc\/article\/32\/12\/e250167\/75908\/Clinical-relevance-of-the-thyroid-differentiation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,17]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1530\/erc-25-0167","relation":{},"ISSN":["1479-6821","1351-0088"],"issn-type":[{"value":"1479-6821","type":"electronic"},{"value":"1351-0088","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,17]]},"article-number":"e250167"}}